Consensus review of the clinical utility of dna content cytometry in prostate cancer
1993; Wiley; Volume: 14; Issue: 5 Linguagem: Inglês
10.1002/cyto.990140508
ISSN1097-0320
AutoresT. Vincent Shankey, Olli Kallioniemi, James M. Koslowski, Michael R. Lieber, Brian H. Mayall, Gary J. Miller, Gary J. Smith,
Tópico(s)Urologic and reproductive health conditions
ResumoCytometryVolume 14, Issue 5 p. 497-500 Special ReportFree Access Consensus review of the clinical utility of dna content cytometry in prostate cancer† T. Vincent Shankey, Corresponding Author T. Vincent Shankey Departments of Urology and Pathology, Loyola University Medical Center, MaywoodDepartment of Urology, Loyola University Medical Center, 2160 South First Avenue, Maywood, IL 60153Search for more papers by this authorOllie-Pekka Kallioniemi, Ollie-Pekka Kallioniemi Molecular Cytometry Division, Department of Lab Medicine, UCSF, San Francisco, CaliforniaSearch for more papers by this authorJames M. Koslowski, James M. Koslowski Department of Urology, Northwestern University Medical Center, Chicago, IllinoisSearch for more papers by this authorMichael L. Lieber, Michael L. Lieber Department of Urology, Mayo Clinic, Rochester, MinnesotaSearch for more papers by this authorBrian H. Mayall, Brian H. Mayall Molecular Cytometry Division, Department of Lab Medicine, UCSF, San Francisco, CaliforniaSearch for more papers by this authorGary Miller, Gary Miller Department of Pathology, University of Colorado Health Sciences Center, Denver, ColoradoSearch for more papers by this authorGary J. Smith, Gary J. Smith Department of Pathology, University of North Carolina, Chapel Hill, North CarolinaSearch for more papers by this author T. Vincent Shankey, Corresponding Author T. Vincent Shankey Departments of Urology and Pathology, Loyola University Medical Center, MaywoodDepartment of Urology, Loyola University Medical Center, 2160 South First Avenue, Maywood, IL 60153Search for more papers by this authorOllie-Pekka Kallioniemi, Ollie-Pekka Kallioniemi Molecular Cytometry Division, Department of Lab Medicine, UCSF, San Francisco, CaliforniaSearch for more papers by this authorJames M. Koslowski, James M. Koslowski Department of Urology, Northwestern University Medical Center, Chicago, IllinoisSearch for more papers by this authorMichael L. Lieber, Michael L. Lieber Department of Urology, Mayo Clinic, Rochester, MinnesotaSearch for more papers by this authorBrian H. Mayall, Brian H. Mayall Molecular Cytometry Division, Department of Lab Medicine, UCSF, San Francisco, CaliforniaSearch for more papers by this authorGary Miller, Gary Miller Department of Pathology, University of Colorado Health Sciences Center, Denver, ColoradoSearch for more papers by this authorGary J. Smith, Gary J. Smith Department of Pathology, University of North Carolina, Chapel Hill, North CarolinaSearch for more papers by this author First published: 1993 https://doi.org/10.1002/cyto.990140508Citations: 89 † These consensual guidelines and recommendations address the potential utility of DNA cytometry in characterizing human malignancies. They are provided to inform laboratory personnel, pathologists, and clinicians about DNA cytometry. For individual patients, use of DNA cytometry, selection of specific techniques, and interpretation and utilization of results remains the responsibility of the attending physicians. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume14, Issue51993Pages 497-500 ReferencesRelatedInformation
Referência(s)